Blocking a protein called LRRK2 can prevent some of the symptoms of Parkinson’s disease in a mouse model of the disease, researchers reported online today in Nature Medicine.

In the following video, several New York-based scientists describe how these animal models of Parkinson’s are helping researchers discover new drugs that inhibit aberrant LRRK2 activity and could perhaps ultimately treat people suffering from the neurodegenerative disease.